Spark sets off gene therapy debate with $850K sticker on Luxturna

Spark sets off gene therapy debate with $850K sticker on Luxturna

Spark Therapeutics' Luxturna will cost $850,000, the company announced Wednesday.

There's a new medicine atop of pharma's global pricing charts, and it's Spark Therapeutics' Luxturna. After winning FDA approval in December, the company said Wednesday its gene therapy will cost $850,000, or $425,000 per eye before discounts.